Journal article · Cochlear implants← The news desk

✦ The Dispatch

Cochlear implantation for sensorineural hearing loss caused by neonatal hyperbilirubinemia

A dispatch from PubMed — filed

Hyperbilirubinemia is a leading cause of sensorineural hearing loss (SNHL) and auditory neuropathy spectrum disorder (ANSD) in neonates. This review synthesizes current evidence to describe key aspects of cochlear implantation (CI) in neonates with hyperbilirubinemia....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

Clinical Takeaway

Cochlear implantation can benefit children with sensorineural hearing loss or auditory neuropathy spectrum disorder caused by neonatal hyperbilirubinemia, but audiologists should ensure thorough auditory neuropathy workup before proceeding, as outcomes may differ from other CI candidates.

Why It Matters

Neonatal hyperbilirubinemia is a preventable but globally prevalent cause of permanent pediatric hearing loss, and synthesizing CI outcome evidence helps guide implantation decisions in this clinically distinct population.

Key Points
  1. 01Neonatal hyperbilirubinemia (severe newborn jaundice) can cause permanent sensorineural hearing loss or auditory neuropathy spectrum disorder (ANSD).
  2. 02Review synthesizes evidence on cochlear implant outcomes specifically in this etiology group.
  3. 03ANSD from hyperbilirubinemia primarily damages the auditory nerve/brainstem, not the cochlear hair cells — this has CI candidacy implications.
  4. 04Outcomes data may differ from CI recipients with other etiologies; careful pre-implant assessment is essential.
  5. 05This is a review article; strength depends on quality and number of underlying studies included.
Claims & Evidence

Cochlear implantation produces meaningful outcomes for children with sensorineural hearing loss caused by neonatal hyperbilirubinemia.

studypartially supported

Neonatal hyperbilirubinemia can cause auditory neuropathy spectrum disorder in addition to sensorineural hearing loss.

studysupported
Research metadata
PMID
42680665
DOI
10.1016/j.semperi.2026.152293.
Journal
Seminars in Perinatology
Publication type
review
Evidence level
2a
Population
Children with sensorineural hearing loss or auditory neuropathy spectrum disorder secondary to neonatal hyperbilirubinemia
Intervention
Cochlear implantation

Primary outcomes

Cochlear implant outcomes (hearing and speech/language development); Candidacy criteria for CI in hyperbilirubinemia-related hearing loss

Related stories